Handbook of Diagnosis and Treatment of Bipolar Disorders

Author: Terence A. KetterPublisher: American Psychiatric Publishing, Inc.Paperback:ISBN 10: 9781585623136ISBN 13: 978-1585623136This readable guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. Handbook of Diagnosis and Treatment of Bipolar Disorders emphasizes recent controlled studies and U.S. Food and Drug Administration (FDA) approved indications and translates these data into the real world of clinical practice. The contributions of the eleven chapter authors from Stanford University reflect more than a decade of clinical research and treatment undertaken at that institution, including advances in diagnosis and interventions supported by controlled studies. The manual provides crucial information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations such as children, women, and older adults and patients with particularly challenging illness courses such as rapid cycling. This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. The manual describes all FDA-approved therapies reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase specific dosing, and drug interactions and summarizes published therapeutic data, as well as results of randomized controlled clinical trials very recently presented at major scientific conferences. Review Dr. Ketter and his colleagues have provided for us a timely clinical guide for one of our most disabling disorders, namely bipolar disorder. A wonderful mix of evidence-based and clinical expertise, this clinical manual sets a new standard for assessment and management manuals for psychiatric disorders. Since the field is rapidly advancing, I will look forward already to the next edition. --David J. Kupfer, M.D., Professor and Chair, Department of Psychiatry, University of Pittsburgh School of Medicine<br /><br />This is a treasure trove of information and guidance for anyone who treats individuals with bipolar disorder or who wants to learn to do so. The authors succeed in their goal of attempting to provide clinicians with the empirical data needed to balance benefit and risk. I'd like to have two copies of this valuable collection of chapters: one for the office as a guide to treatment and one for home as a reference to the rapidly growing literature on the treatment of bipolar disorder. --Ellen Frank, Ph.D., Distinguished Professor of Psychiatry, University of Pittsburgh School of MedicineDr. Ketter and his colleagues have provided for us a timely clinical guide for one of our most disabling disorders, namely bipolar disorder. A wonderful mix of evidence-based and clinical expertise, this clinical manual sets a new standard for assessment and management manuals for psychiatric disorders. Since the field is rapidly advancing, I will look forward already to the next edition. --David J. Kupfer, M.D., Professor and Chair, Department of Psychiatry, University of Pittsburgh School of Medicine From the Inside Flap This readable guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. Handbook of Diagnosis and Treatment of Bipolar Disorders emphasizes recent controlled studies and U.S. Food and Drug Administration (FDA)--approved indications and translates these data into the real world of clinical practice. The contributions of the eleven chapter authors from Stanford University reflect more than a decade of clinical research and treatment undertaken at that institution, including advances in diagnosis and interventions supported by controlled studies. The manual provides crucial information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations -- such as children, women, and older adults -- and patients with particularly challenging illness courses such as rapid cycling. This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. The manual describes all FDA-approved therapies -- reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase--specific dosing, and drug interactions -- and summarizes published therapeutic data, as well as results of randomized controlled clinical trials very recently presented at major scientific conferences. See all Editorial Reviews